メトホルミン関連脳病は珍しいが深刻な副作用である:症例報告
Anna Aoki1, Daisuke Mizu1, Hidenori Higashi1
1Department of Emergency Medicine, Japanese Red Cross Osaka Hospital, Osaka, JPN.
Cureus
|February 19, 2026
まとめ
メトホルミン関連脳症は,2型糖尿病治療の希少な合併症であり,特に腎臓に問題のある患者の場合です. メトホルミンの投与を中止し,血液透析を開始するなど,迅速な診断と治療は,迅速な回復につながる可能性があります.
科学分野:
- ネフロロジーはネフロロジーを用います.
- 神経学 神経学とは
- 薬理学 薬理学とは
背景:
- メトホルミンは,2型糖尿病の一般的な第一線治療である.
- メトホルミン関連脳症は,まれだが重度の副作用である.
- 腎機能障害は,この状態のリスクを高めます.
研究 の 目的:
- ヘモダイアリスを受けている患者のメトホルミン関連脳症の症例を提示する.
- この状態の臨床的およびイメージングの特徴を強調するために.
- 腎機能不全患者のメトフォーミン処方に注意を払うことの重要性を強調する.
主な方法:
- 糖尿病性腎不全を患った44歳の女性で,ヘモダイアリスを受けているケース報告です.
- 臨床的な表象には,筋痛症,一般的弱さ,歩行障害,代謝性アシドーシス,および乳糖過多症が含まれていました.
- 脳のMRIは,双方の基礎性ガンジアの高強度を示した.
主要な成果:
- 患者の症状とMRIの結果は,メトホルミンの中止と新興血液透析後に急速に改善しました.
- メトホルミン関連脳症の診断が確認されました.
- このケースは,不適切なメトホルミン使用による重度の神経学的合併症の可能性を強調しています.
結論:
- メトホルミン関連脳症は,腎機能不全で不適切な処方で起こり得る深刻な副作用です.
- 救急医療の医師は,この状態に対して警戒しなければなりません.
- 血液透析を含む早期の認識と管理は,患者の回復に不可欠です.
関連する概念動画
Oral Hypoglycemic Agents: Biguanides and Glitazones
702
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
702
Hypoglycemia and Glucagon
1.0K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K
Inborn Errors of Metabolism
932
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
932
Insulin: Dosing Regimen and Adverse Effects
874
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
874
Drug Toxicity: Risk factors
27
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
27
Drug toxicity: Drug–Drug Interaction
38
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
38

